• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[心肌血运重建:冠状动脉搭桥术还是支架置入术?]

[Revascularization of myocardium: coronary artery bypass grafting or stenting?].

作者信息

Simonenko V B, Borisov I A, Bletkin A N, Zakharov S V, Dalinin V V

出版信息

Klin Med (Mosk). 2008;86(3):13-7.

PMID:18441697
Abstract

The aim of the study was comparative analysis of long-term results (5 years) after coronary angioplasty and stenting (CAS) and coronary artery bypass grafting (CABG). The results of the treatment of 1100 patients with coronary heart disease, operated since 1999 to 2006 year, were analyzed. 720 (65.5%) patients had undergone CABG (group 1), 226 (20.5%) had had an implantation of stents with pharmaceutical coverage (group 2) 154 (14%) had been implanted with stents without pharmaceutical coverage (group 3). Clinical examination as a rule had occurred before operation, 29-30 days after operation and in every 12 months after discharge from the hospital. Five years survival rate in group of CABG patients was 85.9% and in groups of CAS patients it was 84.1% and 70.8% respectively. Restenosis occurred more frequently in CAS patients: in group 2 in 18.1% patients, in group 3--in 70.1% In group of CABG patients acute myocardial infarction occurred in 11.9% cases to the end of 5th year, in groups 2 and 3 this index was 10.9% and 18.3% respectively. Angina pectoris was absent in 1 year in CABG patients (62%) than in CAS patients (46.7% and 24.3% in groups 2 and 3 respectively; p < 0.05). Comparing results of CAS with use of stents with and without pharmaceutical coverage, the best clinical result was in the group with implanted stents of new generation. Relatively better clinical effect during 5 years occurred in CABG patients.

摘要

本研究的目的是对冠状动脉血管成形术和支架植入术(CAS)以及冠状动脉旁路移植术(CABG)后的长期结果(5年)进行比较分析。分析了1999年至2006年期间接受手术的1100例冠心病患者的治疗结果。720例(65.5%)患者接受了CABG(第1组),226例(20.5%)接受了药物涂层支架植入(第2组),154例(14%)接受了无药物涂层支架植入(第3组)。通常在手术前、术后29 - 30天以及出院后每12个月进行临床检查。CABG患者组的5年生存率为85.9%,CAS患者组的5年生存率分别为84.1%和70.8%。CAS患者再狭窄发生率更高:第2组为18.1%的患者,第3组为70.1%。到第5年末,CABG患者组急性心肌梗死发生率为11.9%,第2组和第3组该指标分别为10.9%和18.3%。CABG患者术后1年无心绞痛的比例(62%)高于CAS患者(第2组和第3组分别为46.7%和24.3%;p < 0.05)。比较使用有药物涂层和无药物涂层支架的CAS结果,最佳临床结果出现在植入新一代支架的组中。CABG患者在5年期间临床效果相对更好。

相似文献

1
[Revascularization of myocardium: coronary artery bypass grafting or stenting?].[心肌血运重建:冠状动脉搭桥术还是支架置入术?]
Klin Med (Mosk). 2008;86(3):13-7.
2
Long-term safety and efficacy of percutaneous coronary intervention with stenting and coronary artery bypass surgery for multivessel coronary artery disease: a meta-analysis with 5-year patient-level data from the ARTS, ERACI-II, MASS-II, and SoS trials.经皮冠状动脉介入治疗联合支架置入术与冠状动脉旁路移植术治疗多支冠状动脉疾病的长期安全性和疗效:一项基于ARTS、ERACI-II、MASS-II和SoS试验5年患者水平数据的荟萃分析。
Circulation. 2008 Sep 9;118(11):1146-54. doi: 10.1161/CIRCULATIONAHA.107.752147. Epub 2008 Aug 25.
3
10-year follow-up of a prospective randomized trial comparing bare-metal stenting with internal mammary artery grafting for proximal, isolated de novo left anterior coronary artery stenosis the SIMA (Stenting versus Internal Mammary Artery grafting) trial.一项比较裸金属支架置入术与乳内动脉搭桥术治疗近端孤立性初发左前冠状动脉狭窄的前瞻性随机试验的10年随访:SIMA(支架置入术与乳内动脉搭桥术)试验
J Am Coll Cardiol. 2008 Sep 2;52(10):815-7. doi: 10.1016/j.jacc.2008.05.037.
4
Five year clinical effect of coronary stenting and coronary artery bypass grafting in renal insufficient patients with multivessel coronary artery disease: insights from ARTS trial.肾功不全的多支冠状动脉疾病患者冠状动脉支架置入术与冠状动脉旁路移植术的五年临床疗效:来自ARTS试验的见解
Eur Heart J. 2005 Aug;26(15):1488-93. doi: 10.1093/eurheartj/ehi288. Epub 2005 Apr 28.
5
Comparison of drug-eluting stents and coronary artery bypass surgery for the treatment of multivessel coronary disease: three-year follow-up results from a single institution.药物洗脱支架与冠状动脉搭桥手术治疗多支冠状动脉疾病的比较:单机构三年随访结果
Circulation. 2009 Apr 21;119(15):2040-50. doi: 10.1161/CIRCULATIONAHA.108.819730. Epub 2009 Apr 6.
6
Long-term clinical outcome of coronary artery stenting or coronary artery bypass grafting in patients with multiple-vessel disease.多支血管病变患者冠状动脉支架置入术或冠状动脉旁路移植术的长期临床结局
J Thorac Cardiovasc Surg. 2008 Aug;136(2):500-6. doi: 10.1016/j.jtcvs.2007.11.050.
7
Coronary artery bypass surgery versus percutaneous coronary artery intervention in patients on chronic hemodialysis: does a drug-eluting stent have an impact on clinical outcome?慢性血液透析患者的冠状动脉搭桥手术与经皮冠状动脉介入治疗:药物洗脱支架对临床结局有影响吗?
J Card Surg. 2009 May-Jun;24(3):234-9. doi: 10.1111/j.1540-8191.2008.00789.x.
8
Improved patient outcomes when transmyocardial revascularization is used as adjunctive revascularization.当心肌血运重建用作辅助性血运重建时,患者预后得到改善。
Heart Surg Forum. 2003;6(5):328-30.
9
Nonrandomized comparison of coronary artery bypass surgery and percutaneous coronary intervention for the treatment of unprotected left main coronary artery disease in octogenarians.八旬老人非保护左主干冠状动脉疾病治疗中冠状动脉搭桥手术与经皮冠状动脉介入治疗的非随机对照比较
Circulation. 2008 Dec 2;118(23):2374-81. doi: 10.1161/CIRCULATIONAHA.107.727099. Epub 2008 Nov 24.
10
Comparison of off-pump coronary artery bypass grafting with percutaneous coronary intervention versus drug-eluting stents for three-vessel coronary artery disease.非体外循环冠状动脉搭桥术与经皮冠状动脉介入治疗及药物洗脱支架治疗三支血管冠状动脉疾病的比较。
Ann Thorac Surg. 2008 Nov;86(5):1438-43. doi: 10.1016/j.athoracsur.2008.07.040.

引用本文的文献

1
Genetic markers of the risk of coronary heart disease and coronary artery thrombosis developing in the Kazakh population.哈萨克族人群中冠心病和冠状动脉血栓形成风险的遗传标志物。
Caspian J Intern Med. 2023 Spring;14(2):249-256. doi: 10.22088/cjim.14.2.249.